ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns

Uso generalizado de Nirmatrelvir más ritonavir (Paxlovid): Algunos planteamientos

David Sánchez Fabraa,

Corresponding author

davidsanchezfabra@gmail.com

Corresponding author.

, Tina Herrero Jordánb

a F.E.A (Facultativo Especialistas de Área) de Medicina Interna, Servicio de Medicina Interna del Hospital Reina Sofía de Tudela, Tudela, Navarra, Spain

b F.E.A (Facultativo Especialista de Área) de Neumología, Servicio de Medicina Interna del Hospital Reina Sofía de Tudela, Tudela, Navarra, Spain

Read

798

Times
was read the article

140

Total PDF

658

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2022.04.007

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	23	3	26
2024 November	22	2	24
2024 October	26	7	33
2024 September	36	12	48
2024 August	44	22	66
2024 July	19	6	25
2024 June	15	2	17
2024 May	22	1	23
2024 April	31	8	39
2024 March	31	10	41
2024 February	40	6	46
2024 January	49	1	50
2023 December	28	2	30
2023 November	40	2	42
2023 October	58	8	66
2023 September	39	1	40
2023 August	16	0	16
2023 July	4	0	4
2023 June	5	3	8
2023 May	6	2	8
2023 April	4	0	4
2023 March	14	6	20
2023 February	86	34	120
2022 June	0	2	2

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Outpatient parenteral antibiotic therapy (OPAT)...

Enferm Infecc Microbiol Clin. 2024;42:581-7

Corrigendum a: Ecografía clínica:...

Enferm Infecc Microbiol Clin. 2024;42:281

The current status of arboviruses with major...

Enferm Infecc Microbiol Clin. 2024;42:516-26

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter